Categories: CancerNews

NYSE Content Advisory: Pre-Market Update + Automakers await 5-year tariff relief extension

NEW YORK, Oct. 17, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

Kristen Scholer delivers the pre-market update on October 17th

  • Stocks are lower early Friday after regional bank reports created concerns over bad loans. Loose lending practices pushed traders into safe havens. Activity in the banking sector could inform the Fed’s next decision on interest rates.  
  • Tariff relief is expected for the auto industry after a lobbying push according to reports. The Commerce Department will announce a five-year extension for an agreement that allows carmakers to reduce what they pay in tariffs on car imports.
  • Koom 2025 kicked off yesterday in Brooklyn. The three-day conference celebrates Korean start-up culture, innovation, and K-Pop. Korean business leaders will be in attendance.


Opening Bell

The Breast Cancer Research Foundation highlights its mission to end breast cancer by advancing the world’s most promising research


Closing Bell


National Fallen Firefighters Foundation honors and remembers 176 Fallen Firefighters


Click here to download the NYSE TV App

View original content to download multimedia:https://www.prnewswire.com/news-releases/nyse-content-advisory-pre-market-update–automakers-await-5-year-tariff-relief-extension-302587581.html

SOURCE New York Stock Exchange

Staff

Recent Posts

More Than a Meal Plan: The Clinical Impact of a Kidney Dietitian

NORTHAMPTON, MA / ACCESS Newswire / December 26, 2025 / Specialized nutrition experts are key…

56 minutes ago

President Trump’s Executive Marijuana Action Exposes the Truth-How the DEA Delayed Medicine While Protecting Everything Else

"Despite clear congressional mandates and FDA authorization, the Drug Enforcement Administration failed to act within…

56 minutes ago

From Follower to Force: China’s Biotech Sector Enters the Global Clinical Mainstream

WASHINGTON, Dec. 26, 2025 /PRNewswire/ -- Over the past decade, China has evolved from a biotechnology…

4 hours ago

Aptevo Therapeutics Announces 1-for-18 Reverse Stock Split

SEATTLE, WA / ACCESS Newswire / December 26, 2025 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a…

7 hours ago

Celularity CEO Comments on Centers for Medicare & Medicaid Services’ Withdrawal of Skin Substitute Local Coverage Determinations

While Celularity’s Biovance® and Biovance 3L products remained eligible for Medicare coverage under the now-withdrawn…

7 hours ago

Arcadia Biosciences (RKDA) Receives Termination Notice of the Proposed Business Combination with Roosevelt Resources

DALLAS, Dec. 26, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and…

7 hours ago